Paper2848486
Group and strain-specific neutralization sites of infectious bursal disease virus defined with monoclonal antibodies.
Snyder DB and 3 others. Avian Dis, 1988. Cited by 76 papers, by iCite.
Cite this record
ConductScience Library. Group and strain-specific neutralization sites of infectious bursal disease virus defined with monoclonal antibodies. Papers, record 2848486. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2848486
- Cell line
- MCA B293 papers
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Group and strain-specific neutralization sites of infectious bursal disease virus defined with monoclonal antibodies.
- PubMed
Connected records4
Records in the library's other databases whose lists name this one, each read from that database's own release: up to 20 of each kind, the most connected first.
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antibodies, Monoclonal | Major topic |
| Antigens, Viral | Major topic |
| Infectious bursal disease virus | Major topic |
| Reoviridae | Major topic |
| Animals | |
| Antibody Specificity | |
| Blotting, Western | |
| Enzyme-Linked Immunosorbent Assay | |
| Hybridomas | |
| Mice | |
| Neutralization Tests |
Source PubMed
Cited by14
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 76 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 26502988 | Efficient self-assembly and protective efficacy of infectious bursal disease virus-like particles by a recombinant baculovirus co-expressing precursor polyprotein and VP4. | Virol J | 2015 | https://conductscience.org/library/papers/26502988 | PubMed |
| 23024743 | Protective vaccination against infectious bursal disease virus with whole recombinant Kluyveromyces lactis yeast expressing the viral VP2 subunit. | PLoS One | 2012 | https://conductscience.org/library/papers/23024743 | PubMed |
| 17881448 | Molecular and structural bases for the antigenicity of VP2 of infectious bursal disease virus. | J Virol | 2007 | https://conductscience.org/library/papers/17881448 | PubMed |
| 16940532 | Transcriptional profiling reveals a possible role for the timing of the inflammatory response in determining susceptibility to a viral infection. | J Virol | 2006 | https://conductscience.org/library/papers/16940532 | PubMed |
| 15331738 | A recombinant Newcastle disease virus (NDV) expressing VP2 protein of infectious bursal disease virus (IBDV) protects against NDV and IBDV. | J Virol | 2004 | https://conductscience.org/library/papers/15331738 | PubMed |
| 15222739 | Very virulent infectious bursal disease virus in Egypt: epidemiology, isolation and immunogenicity of classic vaccine. | Vet Res Commun | 2004 | https://conductscience.org/library/papers/15222739 | PubMed |
| 10074133 | Adaptation of very virulent infectious bursal disease virus to chicken embryonic fibroblasts by site-directed mutagenesis of residues 279 and 284 of viral coat protein VP2. | J Virol | 1999 | https://conductscience.org/library/papers/10074133 | PubMed |
| 8856029 | Epitope mapping of capsid proteins VP2 and VP3 of infectious bursal disease virus. | Arch Virol | 1996 | https://conductscience.org/library/papers/8856029 | PubMed |
| 7832521 | Development of an efficient bioprocess for poultry vaccines using high-density insect cell culture. | Ann N Y Acad Sci | 1994 | https://conductscience.org/library/papers/7832521 | PubMed |
| 7682403 | Nucleotide sequence analysis of the serotype-specific epitope of infectious pancreatic necrosis virus. | Arch Virol | 1993 | https://conductscience.org/library/papers/7682403 | PubMed |
| 1850233 | Comparison of neutralizing antigens of recent isolates of infections bursal disease virus. | Arch Virol | 1991 | https://conductscience.org/library/papers/1850233 | PubMed |
| 1333761 | Naturally occurring-neutralizing monoclonal antibody escape variants define the epidemiology of infectious bursal disease viruses in the United States. | Arch Virol | 1992 | https://conductscience.org/library/papers/1333761 | PubMed |
| 1333752 | Biological roles of the major capsid proteins and relationships between the two existing serotypes of infectious bursal disease virus. | Arch Virol | 1992 | https://conductscience.org/library/papers/1333752 | PubMed |
| 1329340 | Genetic mechanisms of antigenic variation in infectious bursal disease virus: analysis of a naturally occurring variant virus. | Virus Genes | 1992 | https://conductscience.org/library/papers/1329340 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/2848486
GET https://conductscience.org/api/papers/v1/2848486/authors